Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Journal of Experimental Therapeutics & Oncology|November 11, 2011
CD22 as a target for cancer therapyXiao Tu, Theresa LaVallee, Robert LechleiderInvestigational New Drugs|February 29, 2012
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumorsChristina M Annunziata, Elise C Kohn, Patricia LoRusso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemiaRobert J Kreitman, Martin S Tallman, Tadeusz Robak, et al.BMC Cell Biology|July 5, 2002
A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs)Yin Lin, Jennifer Martin, Cornelia Gruendler, et al.Pageof 1